Glutathione S-Transferase it in Colorectal Tumors Is Predictive for Overall Survival

Cancer Research

Volumn 55, Issue 12, 1995, Pages 2696-2702

  Mulder, Theo P J ^a   Verspaget, Hein W ^b   Sier, Cornells F M ^b   Roelofs, Hennie M J ^a   Ganesh, Sjam ^b   Griffioen, Gerrit ^b   Peters, Wilbert H M ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE TRANSFERASE;

ADULT; AGE; AGED; ARTICLE; CANCER SURVIVAL; COLON ADENOCARCINOMA; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME LOCALIZATION; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; RECTUM CARCINOMA; STATISTICAL ANALYSIS;

ADENOCARCINOMA; ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; COLORECTAL NEOPLASMS; COMPARATIVE STUDY; FEMALE; FOLLOW-UP STUDIES; GLUTATHIONE TRANSFERASE; HUMAN; ISOENZYMES; MALE; MIDDLE AGE; NEOPLASM STAGING; PREDICTIVE VALUE OF TESTS; SEX CHARACTERISTICS; SUPPORT, NON-U.S. GOV'T; SURVIVAL ANALYSIS; TIME FACTORS; TUMOR MARKERS, BIOLOGICAL;

EID: 0028979440     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (50)

1. Boyer, T. D., and Kenney, W. C. Preparation, characterization and properties of glutathione S-transferases. Biochem. Pharmacol. Toxicol., 1: 297–363, 1985.
2. Mannervik, B. The isoenzymes of glutathione S-transferase. Adv. Enzymol., 57: 357–417, 1985.
3. Tew, K. D. Glutathione-associated enzymes in anticancer drug resistance. Cancer Res., 54: 4313–4320, 1994.
4. Tsuchida, S., and Sato, K. Glutathione transferases and cancer. Crit. Rev. Biochem. Mol. Biol., 27: 337–384, 1992.
5. Meyer, J. D., Coles, B., Pemble, S. E. Gilmore, K. S., Fraser, G. M., and Ketterer, B. θ, a new class of glutathione transferases purified from rat and man. Biochem. J., 274: 409–414, 1991.
6. Peters, W. H. M., Boon, C. E. W., Roelofs, H. M. J., Wobbes, T., Nagengast, F. M., and Kremers, P. G. Expression of drug-metabolizing enzymes and P-170 glycoprotein in colorectal carcinoma and normal mucosa. Gastroenterology, 103: 448–455, 1992.
7. Howie, A. F., Forrester, L. M., Glancey, M. J., Schlager, J. J., Powis, G., Beckett, G. J., Hayes, J. D., and Wolf, C. R. Glutathione S-transferase and glutathione peroxidase expression in normal and tumour human tissues. Carcinogenesis (Lond.), 11: 451–458, 1990.
8. Capper, M. L., Hoffman, S. J., and Tew, K. D. Glutathione S-transferases in normal and malignant human colon tissue. Biochim. Biophys. Acta, 1096: 209–216, 1991.
9. Moorghen, M., Cairns, J., Forrester, L. M., Hayes, J. D., Hall, A., Cattan, A. R., Wolf, C. R., and Harris, A. L. Enhanced expression of glutathione S-transferases in colorectal carcinoma compared to non-neoplastic mucosa. Carcinogenesis (Lond.), 12: 13–17, 1991.
10. Gilbert, L., Elwood, L. J., Merino, M., Masood, S., Barnes, R., Steinberg, S. M., Lazarous, D. F., Pierce, L., d'Angelo, T., Moscow, J. A., Townsend, A. J., and Cowan, K. H. A pilot study of σ-class glutathione S-transferase expression in breast cancer: correlation with estrogen receptor expression and prognosis in node-negative breast cancer. J. Clin. Oncol., 11: 49–58, 1993.
11. Dukes, C. E. The classification of cancer of the rectum. J. Pathol., 35: 323–332, 1932.
12. Astler V. B., and Coller, F. A. The prognostic significance of direct extension of carcinoma of the colon and rectum. Ann. Surg., 139: 846–852, 1954.
13. Beart, R. W., van Heerden, J. A., and Beahrs, O. H. Evolution in the pathologic staging of carcinoma of the colon. Surg. Gynecol. Obstet., 146: 257–259, 1978.
14. Lowry, O. H., Rosebrough, N. J., Fan, A. L., and Randall, R. J. Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193: 265–275, 1951.
15. Habig, W. H., Pabst, M. J., and Jakoby W. B. Glutathione S-transferases. The first enzymatic step in mercapturic acid formation. J. Biol. Chem., 249: 7130–7139, 1974.
16. Cox, D. R. Regression models and life-tables. J. R. Stat. Soc. B, 34: 187–220, 1972.
17. Kaplan, E. L., and Meier, P. Nonparametric estimation from incomplete observations. J. Am. Stat. Assoc., 53: 457–481, 1958.
18. Strange R. C., Matharoo, B., Faulder, G. C., Jones, P., Cotton, W., Elder, J. B., and Deakin, M. The human glutathione S-transferase: a case-control study of the incidence of the GST1 0 phenotype in patients with adenocarcinoma. Carcinogenesis (Lond.), 12: 25–28, 1991.
19. Bell, D. A., Taylor, J. A., Paulson, D. F., Robertson, C. N., Mohler, J. L., and Lucier, G. W. Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer. J. Natl, Cancer Inst., 85: 1159–1164, 1993.
20. Brockmdller, J., Kerb, R., Drakoulis, N., Nitz, M., and Roots, I. Genotype and phenotype of glutathione S-transferase class µ and Ψ in lung cancer patients and controls. Cancer Res., 53: 1004–1011, 1993.
21. Zhong, S., Wyllie, A. H., Barnes, D., Wolf, C. R., and Spurr, N. K. Relationship between the GSTM1 genetic polymorphism and susceptibility to bladder, breast and colon cancer. Carcinogenesis (Lond.), 14: 1821–1824, 1993.
22. Hirvonen, A., Husgafvel-Pursiainen, K., Anttila, S., and Vainio, H. The GSTM1 null genotype as a potential risk modifier for squamous cell carcinoma of the lung. Carcinogenesis (Lond.), 14: 1479–1481, 1993.
23. Nazar-Steward, V., Motulsky, A. G., Eaton, D. L., White, E., Hornung, S. K. Leng, Z-T., Stapleton, P., and Weiss, N. S. The glutathione S-transferase p. polymorphism as a marker for susceptibility to lung carcinoma. Cancer Res., 53: 2313–2318, 1993.
24. Lafuente, A., Pujol, F., Carretero, P., PeYez Villa, J., and Cuchi, A. Human glutathione S-transferase µ. (GSTµ.) deficiency as a marker for the susceptibility to bladder and larynx cancer among smokers. Cancer Lett., 68: 49–54, 1993.
25. Peters, W. H. M., Kock, L., Nagengast, F. M., and Roelofs, H. M. J. Immunodetection with a monoclonal antibody of glutathione S-transferase µ. in patients with and without carcinomas. Biochem. Pharmacol., 39: 591–597, 1990.
26. Armitage, N. C., Ballantyne, K. C. Evans, D. F., Clarke, P., Sheffield, J., and Hardcastle, J. D. The influence of tumour cell DNA content on survival in colorectal cancer: a detailed analysis. Br. J. Cancer, 62: 852–856, 1990.
27. Norheim-Andersen, S. N., Rognum, T. O., Lund, E., Meling, G. I., and Hauge, S. Strong HLA-DR expression in large bowel carcinomas is associated with good prognosis. Br. J. Cancer, 68: 80–85, 1993.
28. de Bruine, A. P., Wiggers, Th., Beck, C., Volovics, A., von Meyenfeld, M., Arends, J. W., and Bosnian, F. T. Endocrine cells in colorectal adenocarcinomas: incidence, hormone profile and prognostic relevance. Int. J. Cancer, 54: 765–771, 1993.
29. Deans, G. T., Williamson, K., Hamilton, P., Hcatley, M., Arthurs, K., Patterson, C. C., Rowlands, B. J. Parks, T. G., and Spence, R. A. DNA densitometry of colorectal cancer. Gut, 34: 1566–1571, 1993.
30. Yamaguchi, A., Nakagawara, G., Kurosaka, Y., Nishimura, G., Yonemura, Y., and Miyazaki, I. p53 immunoreaction in endoscopic biopsy specimens of colorectal cancer, and its prognostic significance. Br. J. Cancer, 68: 399–402, 1993.
31. Jen, J., Kim, H., Piantadosi, S., Liu, Z-F., Levitt, R. C., Sistonen, P., Kinzler, K. W., Vogelstein, B., Hamilton, S. R. Allelic loss of chromosome 18q and prognosis in colorectal cancer. N. Engl. J. Med., 331: 213–221, 1994.
32. Ganesh, S., Sier, C. F. M., Griffioen, G., Vloedgravcn, H. J. M., de Boer, A., Welvaart, K., van der Velde, C. J. H., van Krieken, J. H. J. M., Verheijen, J. H., Lamers, C. B. H. W., and Verspaget, H. W. Prognostic relevance of plasminogen activators and their inhibitors in colorectal cancer. Cancer Res., 54: 4065–4071, 1994.
33. Starzynska, T., Marsh, P. J., Shofield, P. F., Roberts, S. A., Myers, K. A., and Stem, P. L. Prognostic significance of 5T4 oncofetal antigen expression in colorectal carcinoma. Br. J. cancer., 69: 899–902, 1994.
34. Kune, G. A., Kune, S., Field, B., White, R., Brough, W., Schellenberger, R., and Watson, L. F. Survival in patients with large-bowel cancer. Dis. Colon Rectum, 33: 938–946, 1990.
35. Griffin, M. R., Bergstrahl, E. J., Coffey, R. J., Beart, R. W., and Melton, L. J. Predictors of survival after curative resection of carcinoma of the colon and rectum. Cancer (Phila.), 60: 2318–2324, 1987.
36. Wiggers, T., Arends, J. W., Schutte, B., Volovics, L., and Bosnian, F. T. A Multivariate analysis of pathological prognostic indicators in large bowel cancer. Cancer (Phila.), 61: 386–395, 1988.
37. Ponz de Leon, M., Sant, M., Micheli, A., Sacchetti, C., Di Gregorio, C., Fante, R., Zanghieri, G., Melotti, G., and Gatta, G. Clinical and pathologic prognostic indicators in colorectal cancer. Cancer (Phila.), 69: 626–635, 1992.
38. Green, J. B., Timmcke, A. E., Mitchel, W. T., Hicks, T. C., Gathright, J. B., and Ray, J. E. Mucinous carcinoma: just another colon cancer? Dis. Colon Rectum, 36: 49–54, 1993.
39. Peters, W. H. M., Roelofs, H. M. J. van Putten, W. L. J., Jansen, J. B. M. J., Klijn, J. G. M., and Foekens, J. A. Response to adjuvant chemotherapy in primary breast cancer: no correlation with expression of glutathione S-transferases. Br. J. Cancer, 68: 86–92, 1993.
40. Okuyama, K. Maehara, Y., Endo, K., Baba, H., Adachi, Y., Kuwano, M., and Sugimachi, K. Expression of glutathione S-transferase-σ and sensitivity of human gastric cancer cells to cisplatin. Cancer (Phila.), 74: 1230–1236, 1994.
41. Hamada, S-I., Kamada, M., Furumoto, H., Hirao, T., and Aono, T. Expression of glutathione S-transferase-σ in human ovarian cancer as an indicator of resistance to chemotherapy. Gynecol. Oncol., 52: 313–319, 1994.
42. Mekhail-Ishak, K., Hudson, N., Tsoa, M-S., and Batist, G. Implications for therapy of drug-metabolizing enzymes in human colon cancer. Cancer Res., 49: 4866–4869, 1989.
43. Peters, W. H. M., Wormskamp, N. G. M., and Thies, E. Expression of glutathione S-transferases in normal gastric mucosa and in gastric tumors. Carcinogenesis (Lond.), 11: 1593–15%, 1990.
44. Wright, C., Cairns, J., Cantwell, B. J., Cattan, A. R., Hall, A. G., Harris, A. L., and Home, C. H. W. Response to mitoxantrone in advanced breast cancer: correlation with expression of c-erbB-2 protein and glutathione S-transferases. Br. J. Cancer, 65: 271–274, 1992.
45. Murphy, D., McGown, A. T., Hall, A., Cattan, A., Crowther, D., and Fox, B. W. Glutathione S-transferase activity and isoenzyme distribution in ovarian tumour biopsies taken before and after cytotoxic chemotherapy. Br. J. Cancer, 66: 937–942, 1992.
46. van der Zee, A. G. J., van Ommen, B., Meijer, C., Hollema, H., van Bladeren, P. J., and de Vries, E. G. E. Glutathione S-transferase activity and isoenzyme composition in benign ovarian tumours, untreated malignant ovarian tumours, and malignant ovarian tumours after platinum/cyclophosphamide chemotherapy. Br. J. Cancer, 66: 930–936, 1992.
47. 6-alkylguanine-DNA-alkyltransferase and P-glycoprotein in adult patients with leukaemia. Br. J. Haematol., 85: 103–111, 1993.
48. Green, J. A., Robertson, L. J., and Clark, A. H. Glutathione S-transferase expression in benign and malignant ovarian tumours. Br. J. Cancer, 68: 235–239, 1993.
49. Tidefeld, U., Elmhorn-Rosenborg, A., Paul, C., Hoa, X-Y., Mannervik, B., and Eriksson, L. C. Expression of glutathione transferase σ as a predictor for treatment results at different stages of acute nonlymphoblastic leukemia. Cancer Res., 52: 3281–3285, 1992.
50. Grignon, D. J., Abdel-Malak, M., Mertens, W. C., Sakr, W. A., and Shepherd, R. R. Glutathione S-transferase expression in renal cell carcinoma: a new marker of differentiation. Mod. Pathol., 7: 186–189, 1994.